Evidence map›Paper›PMID 21501958›Full record

ReviewCurrent opinion in cell biology2011

The nuclear bodies inside out: PML conquers the cytoplasm.

Arkaitz Carracedo, Keisuke Ito, Pier Paolo Pandolfi

Abstract readReview
In one paragraph

Review in Current opinion in cell biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 45 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. DNA virus replication compartments.Journal of virology · 2014
    Review
  14. Review
  15. Article
  16. Article
  17. Differential Roles of PML Isoforms.Frontiers in oncology · 2013
    Article
  18. Article
  19. Article
  20. A metabolic prosurvival role for PML in breast cancer.The Journal of clinical investigation · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Arkaitz CarracedoCIC bioGUNE, Technology Park of Bizkaia, 48160 Derio, Bizkaia, Spain.
Keisuke Ito
Pier Paolo Pandolfi
Cancer Genetics (United States) · US

Funding

Targeting PML for Leukemia TherapyR01CA142874 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI AVIGAN, DAVID E. · 2010 to 2020
$4.5M
FUSION PROTEINS IN THE MOLECULAR PATHOGENESIS OF APLR01CA074031 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI PANDOLFI, PIER PAOLO · 1997 to 2009
$3.8M
PML, PLZF, NPM AND NUMA IN THE PATHOGENESIS OF APLR01CA071692 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI PANDOLFI, PIER PAOLO · 1996 to 2005
$1.8M
A metabolic role for PML in tumor suppressionR01CA142780 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI PANDOLFI, PIER PAOLO · 2010 to 2014
$1.7M
Targeting PML for therapy in leukemia-initiating cellsK99CA139009 · NCI · BETH ISRAEL DEACONESS MEDICAL CENTER · PI ITO, KEISUKE · 2010 to 2011
$177k
NCI NIH HHS K99 CA139009NCI NIH HHS R01 CA071692NCI NIH HHS R01 CA074031NCI NIH HHS R01 CA142780NCI NIH HHS R01 CA142874
6 · The paper itself

Abstract

The promyelocytic leukemia (PML) protein is the core component of nuclear substructures that host more than 70 proteins, termed nuclear domains 10 or PML-nuclear bodies. PML was first identified as the gene participating in the translocation responsible for the pathogenesis of acute promyelocytic leukemia (APL). The notion that PML is a tumor suppressor gene was soon extrapolated from leukemia to solid tumors. The last decade has radically changed the view of how this tumor suppressor is regulated, how it can be therapeutically targeted, and how it functions. Notably, one of the most recent and striking features uncovered is how PML regulates cellular homeostasis outside its original niche in the nucleus. These new findings open an exciting new area of research in extra-nuclear PML functions.

Indexed as

AnimalsCell NucleusCytoplasmHumansIntranuclear Inclusion BodiesLeukemia, Promyelocytic, AcuteTumor Suppressor ProteinsTumor Suppressor Proteins

Identifiers

PMID21501958
PMCPMC3109131
OpenAlexW2022785969

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.